[
  {
    "ts": "2025-10-14T13:00:04+00:00",
    "headline": "Is Most-Watched Stock Hologic, Inc. (HOLX) Worth Betting on Now?",
    "summary": "Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.",
    "url": "https://finance.yahoo.com/news/most-watched-stock-hologic-inc-130004030.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "904a8fab-e349-3c6e-9a45-d4ee9a62ebfb",
      "content": {
        "id": "904a8fab-e349-3c6e-9a45-d4ee9a62ebfb",
        "contentType": "STORY",
        "title": "Is Most-Watched Stock Hologic, Inc. (HOLX) Worth Betting on Now?",
        "description": "",
        "summary": "Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.",
        "pubDate": "2025-10-14T13:00:04Z",
        "displayTime": "2025-10-14T13:00:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/d0d4ab152198da2f423d92da8a7d22ee",
          "originalWidth": 900,
          "originalHeight": 876,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/H7_MbG.UY.XzK7FHlqhSdQ--~B/aD04NzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d0d4ab152198da2f423d92da8a7d22ee.cf.webp",
              "width": 900,
              "height": 876,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9cdhr7KlQi2r1salrGcJQg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d0d4ab152198da2f423d92da8a7d22ee.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/most-watched-stock-hologic-inc-130004030.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/most-watched-stock-hologic-inc-130004030.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HOLX"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-14T12:35:00+00:00",
    "headline": "HOLX's Enhanced Fibroid Treatment Portfolio Powers GYN Surgical Growth",
    "summary": "Hologic's GYN Surgical segment gains momentum internationally as expanded fibroid treatments support growth.",
    "url": "https://finance.yahoo.com/news/holxs-enhanced-fibroid-treatment-portfolio-123500694.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "382883b6-7d3d-31c1-bdfa-8add80f8fc11",
      "content": {
        "id": "382883b6-7d3d-31c1-bdfa-8add80f8fc11",
        "contentType": "STORY",
        "title": "HOLX's Enhanced Fibroid Treatment Portfolio Powers GYN Surgical Growth",
        "description": "",
        "summary": "Hologic's GYN Surgical segment gains momentum internationally as expanded fibroid treatments support growth.",
        "pubDate": "2025-10-14T12:35:00Z",
        "displayTime": "2025-10-14T12:35:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TNBAnrhWOnvvvNSvMEIuFg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rP7ZEHNft_Sb_FB9M.3i3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/holxs-enhanced-fibroid-treatment-portfolio-123500694.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/holxs-enhanced-fibroid-treatment-portfolio-123500694.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "MDT"
            },
            {
              "symbol": "HOLX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]